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Abstract
Background: Computational strain optimisation methods (CSOMs) have been successfully used to exploit genome-
scale metabolic models, yielding strategies useful for allowing compound overproduction in metabolic cell factories.
Minimal cut sets are particularly interesting since their definition allows searching for intervention strategies that
impose strong growth-coupling phenotypes, and are not subject to optimality bias when compared with simulation-
based CSOMs. However, since both types of methods have different underlying principles, they also imply different
ways to formulate metabolic engineering problems, posing an obstacle when comparing their outputs.
Results: In this work, we perform an in-depth analysis of potential strategies that can be obtained with both methods,
providing a critical comparison of performance, robustness, predicted phenotypes as well as strategy structure and size.
To this end, we devised a pipeline including enumeration of strategies from evolutionary algorithms (EA) and minimal
cut sets (MCS), filtering and flux analysis of predicted mutants to optimize the production of succinic acid in
Saccharomyces cerevisiae. We additionally attempt to generalize problem formulations for MCS enumeration within the
context of growth-coupled product synthesis. Strategies from evolutionary algorithms show the best compromise
between acceptable growth rates and compound overproduction. However, constrained MCSs lead to a larger variety
of phenotypes with several degrees of growth-coupling with production flux. The latter have proven useful in
revealing the importance, in silico, of the gamma-aminobutyric acid shunt and manipulation of cofactor pools in
growth-coupled designs for succinate production, mechanisms which have also been touted as potentially useful for
metabolic engineering.
Conclusions: The two main groups of CSOMs are valuable for finding growth-coupled mutants. Despite the limitations
in maximum growth rates and large strategy sizes, MCSs help uncover novel mechanisms for compound
overproduction and thus, analyzing outputs from both methods provides a richer overview on strategies that can be
potentially carried over in vivo.
Keywords: Genome-scale metabolic models, Computational strain design, Metabolic pathway analysis, Evolutionary
algorithms, Minimal cut sets, Growth-coupled product synthesis
Background
Genome-scale metabolic models (GSMM) are well
proven tools for the in-silico analysis of the metabolism
of living organisms. Indeed, the wide availability of
whole-genome sequencing and annotation tools have en-
abled the reconstruction of a multitude of metabolic net-
works for various organisms [1]. Constraint-based (CB)
modelling approaches allow the usage of GSMMs for
simulation, analysis and strain optimization purposes
which, despite the increasing scale of these models, have
proven useful for a variety of studies. Phenotype predic-
tion methods such as Flux Balance Analysis (FBA) [2]
and its variants for mutant phenotypes [3–5], as well as
Elementary Modes Analysis (EMA) [6] are capable of
providing valuable insights on cell metabolism.
Designing optimized microbial strains for compound
overproduction, however, is achieved through computa-
tional strain optimization methods (CSOMs), providing
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a rational approach for finding intervention strategies, as
opposed to trial-and-error experiments [7, 8]. The pur-
pose of most available CSOMs in the metabolic engin-
eering (ME) context is to find sets of reactions that,
when modified, force the cell to couple fluxes involved
with the production of the desired compound with those
required for cell growth. Growth-coupled phenotypes
can be classified as weak, when compound production is
only forced above a certain growth rate threshold, or
strong when the fluxes driving the production of the de-
sired compound are essential for cell growth [9].
CSOMs can be branched in two main categories:
simulation-based (SB) and EMA-based methods. For
simplification purposes we group bi-level mixed integer
programming (MIP) and metaheuristic methods as SB
methods, due to their similarities in evaluating candidate
strategies, although with different methods for generat-
ing them (as recently reviewed by Maia and co-workers
[8] and Machado et al. [10]).
SB CSOMs mostly derive from the bi-level framework
first presented by Burgard and colleagues in the Opt-
Knock approach [11], defining a strategy where an
optimization layer is subject to the constraints posed by
CB models. Several variations of this MIP problem have
also been proposed to find more robust strategies and
integrate omics data in the search [12, 13]. On the other
hand, the OptGene approach later presented by Patil et
al. [14], first introduced the usage of genetic algorithms
for the optimization layer, which effectively detaches it
from the simulation allowing for more flexible objective
definitions and reducing the computational cost. Several
improvements were subsequently published, including
alternative evolutionary algorithms [15] and multiple ob-
jective functions [16]. Until recently, this type of CSOM
comprised the only computationally feasible choice for
strain optimization in GSMMs.
EMA-based CSOMs, on the other hand, search strat-
egies for the desired ME goals throughout the entire so-
lution space, resulting in predicted phenotypes that are
not reliant on optimality assumptions. This implies an
increase in computational demand, which severely hin-
ders the scalability of most CSOMs of this type [8]. A
prominent example is the concept of minimal cut sets
(MCSs) [17], the smallest intervention targets that block
a certain phenotype.
MCS enumeration algorithms were mostly reliant
upon complete elementary mode (EM) enumeration,
rendering it an infeasible task for models of greater scale
and complexity. Several methods have been developed
to tackle the computational limitations of EMA-based
CSOMs by allowing partial enumeration of EMs through
the use of sampling approaches [18], evolutionary algo-
rithms [19], as well as other methods [20, 21]. The k-
shortest EM method [21] is a relevant example of this,
allowing enumeration of the k smallest EMs using a
MILP (mixed-integer linear programming) approach.
The MCSEnumerator approach recently proposed by
von Kamp et al. [22] successfully employs K-shortest
EM enumeration in a dual linear problem through which
EMs can be mapped to MCSs on the original network,
as demonstrated by Ballerstein and colleagues [23]. The
tool’s feasibility for GSMMs has been demonstrated with
the enumeration of synthetic lethals and knockout strat-
egies for production of various compounds using a
model for Escherichia coli [22]. Erdrich et al. have also
explored this tool as a means to find design strategies
for biofuel production in cyanobacteria [24] and a recent
in vivo study has also confirmed its importance as a ra-
tional strain design tool for itaconate production in
Escherichia coli, albeit using a smaller scale model [25].
Despite the existence of some studies highlighting the
importance of EMA-based CSOMs to solve ME prob-
lems [24, 25], there is a gap regarding the analysis of
these methods’ outputs. Von Kamp and Klamt have re-
cently assessed the feasibility of growth-coupled product
synthesis in various organisms [26]. However, the appli-
cation of these methods for strain optimization is still
limited and few studies have discussed the biological im-
plications of strategies obtained using these approaches.
Recent developments by Harder et al. use an iterative ra-
tional strain design approach with successful in vivo out-
comes, but do not apply MCSs directly as design
strategies, relying instead on continuously applying par-
tial MCSs and updating the metabolic model’s environ-
mental conditions for subsequent enumerations [25].
The comparison between EMA and SB CSOM derived
strategies is also often overlooked. Most SB CSOMs are
subject to optimality bias since they require an objective
function which is often misleading and hard to define in
certain organisms or metabolic systems. EMA-based
CSOMs can now provide a suitable alternative to obtain
highly robust design strategies with a low number of
modifications, but there is a general lack of information
regarding how well these perform against state-of-the-
art SB CSOMs and whether their strategies produce bet-
ter in vivo candidates.
The purpose of this work is to employ EMA-based
and SB CSOMs in strain design applications using a case
study involving the identification of knockout strategies
for the production of succinic acid with Saccharomyces
cerevisiae. To assess the feasibility of these methods,
outputs from both categories are compared and different
formulations of both approaches are also analysed. The
aim is to bridge the gap between EMA and SB CSOMs
by assessing performance metrics for each set of strat-
egies and understanding the advantages and limitations
of each method regarding their usage for ME tasks with
different production and growth demands.
Vieira et al. BMC Bioinformatics          (2019) 20:350 Page 2 of 15
We present a pipeline including strain optimization,
filtering and analysis of design strategies based on previ-
ous developments and packaged it as part of the Meta-
bolic Engineering Workbench (MEW),1 an open-source
Java library developed in-house. Two additional problem
formulations are also presented to allow greater flexibil-
ity of growth-coupled design strategies based on MCSs.
A graphical user interface for the MCS enumeration al-
gorithm was also made available as a plugin for the Opt-
Flux metabolic engineering platform [27].
Results
The methodological pipeline used for this work can be
divided in three key steps as illustrated in Fig. 1. These
steps are detailed in the methods sections.
The primary goal with our workflow is to explore
growth-coupled phenotypes through design strategies
obtained with EMA-based and SB CSOMs. Five different
strain design strategies, described in more detail in the
Methods section, were obtained with SB CSOMs (using
the evolutionary algorithm SPEA2) and EMA-based
CSOMs (with MCSEnumerator) as part of our experi-
mental setup.
Using SPEA2, biomass-product coupling maximization
(EAw) and product minimum maximization (EAm) were
tested, allowing different trade-offs between biomass and
target compound production. EAw includes maximum
cell growth and production flux at maximum cell growth
as two separate objectives, while EAm uses the max-
imum cell growth rate and minimum product flux at
maximum growth as objectives.
For MCSEnumerator, three strategies (MCSe, MCSf
and MCSw) cover previously used and novel approaches
that are more or less strict regarding robustness of the
solutions by different definitions of the undesired spaces.
In MCSe the undesired space contains low product yield
flux vectors with a maximum substrate uptake rate and
maintenance ATP rate above a defined value. In MCSf,
low product yield phenotypes are blocked, assuming a
fixed substrate uptake rate. In MCSw, low product flux
phenotypes are blocked only when biomass fluxes are
above a fraction of the maximum growth rate, aiming to
reach strategies with less strict demands regarding prod-
uct synthesis and its coupling with growth.
The purpose is to compare the five chosen strategies,
considering a ME case study with the production of suc-
cinic acid with Saccharomyces cerevisiae as an objective.
All analyses consider glucose as a carbon source with an
uptake flux of 1.15 mmol.gDW− 1.h− 1 and aerobic condi-
tions. For validation purposes, we also test different
MCS formulations with previously determined Escheri-
chia coli strategies also derived from MCSs. The results
from this case study can be found as part of the Add-
itional file 1.
Strategy performance
First, we compare the predicted performance of strat-
egies from all approaches. The results for this analysis
are highlighted on Fig. 2.
Production robustness
Strategies from the MCSe and MCSf sets provide fully
robust production phenotypes with forced product syn-
thesis even at very low growth rates (strongly-coupled).
SPEA2 and MCSw strategies lead to lower product flux
values and only guarantee product synthesis at higher
growth rates. It is worth noting that a considerable
amount of MCSw strategies do not allow growth-
coupling at all, or do not meet our demand for pro-
duction at 90% of the maximum mutant growth rate.
This explains the need for a filtering step prior to
our analysis.
EAm strategies lead to moderately robust phenotypes
with higher product rates across different cell growth
thresholds, with some of these strategies leading to
strongly growth-coupled production phenotypes. These
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Fig. 1 Brief overview of the pipeline employed in this work. Optimization is performed using two strain design algorithms that produce reaction
deletion strategies. These are filtered according to several criteria so they are compliant with the defined environmental conditions, minimum
growth rate and production demands. The selected strategies are then subjected to various analysis methods
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results are expected, considering the constraints im-
posed upon the various formulations.
The maintenance ATP constraint imposed on the
MCSe formulation seems to negatively affect production
robustness and rates, as this set underperforms the
MCSf regarding these properties.
Cell growth and productivity
MCSf and MCSe strategies appear to be the worst per-
forming strategies when considering cell growth. BPCY
values for these sets are similar and considerably lower
than for EA solutions. Despite the increased product
flux values, strongly coupled MCSs (MCSe and MCSf )
lead to much lower growth rates, which negatively im-
pacts BPCY.
Conversely, the MCSw solution set, with lower pro-
duction rates and robustness, leads to similar BPCY
values since the maximum cell growth is much higher.
EAw solutions reach the highest average BPCY figures,
surpassing the EAm set, which, despite the increased
product flux values, leads to lower maximum growth
rates.
Regarding carbon yields, all strategy sets predict max-
imum glucose uptake, leading to carbon yields that are
directly dependent upon the product flux. Thus, MCSe
and MCSf solutions lead to higher carbon yields,
Fig. 2 Left: Overview of various performance and robustness metrics for the solution sets featured by the analysis of succinate producing
strategies. Displayed metrics: Production robustness (at 1 and 90% of maximum biomass), maximum growth rate, biomass-product coupled yield
and product/substrate carbon yield. Right: Representation of the formulations featured in this case study. Colours match the ones used in the left
part of the image. The undesired flux space is represented in red (only for cMCS enumeration problems), while the expected phenotype is
represented in light green. For evolutionary algorithms, a green arrow represents the objective function
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followed by the EAm and EAw set. MCSw strategies
have noticeably lower production rates, also leading to
lower carbon yields.
The MCSe set appears to lead to slightly higher max-
imum growth rates and BPCY than the MCSf set. Max-
imum carbon yield, however, is lower (due to lower
product rates).
The size of the analysed strategies is not homogeneous
across all groups. MCS derived formulations are guaran-
teed to deliver the smallest solutions for the specified
problem. SPEA2, being a heuristic approach, may lead to
bigger solutions. Despite the large range of solution sizes
for formulations based on this algorithm, EA-derived
strategies with the highest BPCY values contain less than
10 knockouts. Additionally, the smallest strategies for
succinate production are found in these solution sets
(less than 5 knockouts), even though the average solu-
tion size across the entire sets is higher.
MCS derived strategies have low ranges as the number
of solutions increases heavily with the proposed size,
which imposes a computational limit. MCSw solutions
were limited to sizes 3 through 5, while MCSe and MCSf
were achieved with sizes up to 9 deletions. Productivity
appears to increase with solution size in this particular
case. However, the aforementioned changes in robust-
ness and productivity metrics can be verified even when
comparing similar solution sizes.
Phenotype analysis
The main results of the pathway distribution approach
used in this work are depicted on Fig. 3, showing the ac-
tivity of specific pathways towards the goal of achieving
different growth-coupled phenotypes. Average flux
values throughout the strategy sets were compared and
merged into their respective pathways to illustrate this.
Across the solutions from all strategies, there is a de-
creased usage of the oxidative branch of the pentose
phosphate pathway (PPP), as compared to the wild-type.
This correlates with the knockouts themselves on the
pathway, found in EAw and both MCS solution sets.
Flux on the non-oxidative branch is also generally de-
creased, although some reactions leading up to the
amino-acid biosynthetic pathways remain active, which
can be observed on Fig. 3. This can be seen through the
increased usage of alanine, serine, glycine and glutamate
biosynthetic pathways in strongly-coupled strategies and
the EAm set.
The tricarboxylic acid (TCA) cycle is also disrupted in
most of the proposed designs, leading to less active reac-
tions in this pathway. This also leads to a lower activity
in the electron transfer chain. Interestingly, the solutions
from the EAw set, leading to higher growth rates, main-
tain flux in TCA cycle reactions, whereas the solutions
from the remaining strategies do not. This could be
explained by the high usage of fumarate reductase and
the glyoxylate shunt (albeit with smaller flux) which is
the primary mechanism found for succinate production
in EAw solutions, in contrast with 4-aminobutyrate
(GABA) degradation pathways used in strongly-coupled
solutions.
The GABA degradation pathway plays a key role in
the solutions obtained from strongly-coupled strategies.
This pathway, otherwise known as the GABA shunt,
leads to succinate production through degradation of
GABA in the cytosol and serves as the main production
mechanism in all MCSf and MCSe solutions and in a
smaller proportion in EAm. Increased usage of this path-
way seems to directly correlate with higher production
robustness. Similarly, usage of the methylglyoxal cata-
bolic pathway is also increased in solutions from MCSf,
MCSe and EAm strategies. Through further analysis of
the admissible flux ranges using FVA we were also able
to find that GABA shunt fluxes become essential for the
feasibility of most MCSf and MCSe solutions, which also
shows that growth and production are coupled to this
pathway.
It is worth noting that the strongly growth-coupled
phenotypes we found were dependent on the imbalance
of at least one cofactor. This finding is supported by the
fact that the fixed maintenance ATP demand is essential
to impose strong coupling – only weak coupling is
achieved if the maintenance ATP pseudo-reaction
bounds are lower. Additionally, in many MCSf solutions,
the NADPH/NADP balance is disrupted through dele-
tions that force glucose uptake through NADPH
dependent pathways or flux through certain pathways
dependent on these cofactors, such as folate interconver-
sions, or methylglyoxal metabolism. Flux through the
GABA shunt is then required to maintain a steady-state.
These phenomena involving cofactor pools have already
been described as possible mechanisms for growth-
coupled synthesis by Erdrich et al. [24] and Hädicke et
al. [28], although further experimental validation is still
required.
Knockout frequency analysis
Analysis of the specific knockouts included in the ob-
tained strategies is a key feature to determine which are
the most important deletions leading to weak or strong
coupling phenotypes. Figure 4 summarizes the frequency
of the most common knockouts across all formulations.
A common disruption across the solutions from all
strategies is the succinate dehydrogenase complex, a
TCA cycle mitochondrial protein complex supplying
electrons for the transfer chain and catalysing the con-
version of succinate to fumarate. Subunit 2 (EC 1.3.5.1)
of this complex is present in every solution, with sub-
units 3 and 1 being less present (ECs 1.3.5.1 and
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1.3.99.1, respectively), in decreasing order of frequency.
The importance of this disruption may come from the
fact that this is the only available irreversible conversion
of succinate to fumarate.
Glycolysis appears as a target for disruption in strat-
egies with higher production robustness (EAm, MCSe
and MCSf ), with higher frequency of knockouts in ki-
nases involved in glucose phosphorylation, such as
hexokinase or glucokinase. The presence of PGI (EC
5.3.1.9) knockouts in most strategies may help explain
the increased flux in the PPP and alternative glucose
catabolic pathways.
The EA set includes many solutions involving serine
biosynthesis from intermediate metabolites of glycolysis,
blocking a possible branched pathway from glycolysis.
MCS strategies, on the other hand, include knockouts
Fig. 3 Overview of the usage of various pathways for the solutions obtained by each of the different design strategies for succinate production.
The values represent the difference in the proportion of active reactions when compared with the wild-type simulated with parsimonious FBA.
Pathway nomenclature was obtained on BioCyc and matched with KEGG identifiers assigned to reactions on the GSMM
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that block glycolysis before this branching, namely
PGK and GAPD (ECs 2.7.2.3 and 1.2.1.12, respect-
ively), which force the usage of alternative pathways,
such as methylglyoxal catabolism or serine
biosynthesis.
Due to the decreased rates in the oxidative phosphor-
ylation, fermentation appears as an alternative for pyru-
vate catabolism for many solutions. As such, succinate
producing strategies with higher titres tend to include
knockouts in PYRDC (EC 4.1.1.1), ALDD (EC 1.2.1.4)
and ACOAH (3.1.2.1) reactions to reduce the number of
viable alternative pathways that could drive carbon away
from succinate production.
Knockouts in the PPP are somewhat prevalent across
all strategy sets except MCSw. Regarding oxidative-
phase knockouts, G6PDH (EC 1.1.1.49) appears in
strongly-coupled MCSs with relatively high frequencies,
especially in the MCSf set and in the EAw set.
Finally, in the TCA cycle, the cytosolic IDH (EC
1.1.1.42) knockout seems to be a relatively common
occurrence in MCSf solutions, which leads to strongly
coupled succinate production through forced usage of
the TCA cycle producing 2-oxoglutarate in the mito-
chondria and then transported outside to feed the
GABA shunt for cytosolic succinate to be synthesized.
Experimental studies
Two metabolic routes for succinate overproduction from
the TCA cycle have been described in the literature, re-
spectively, the oxidative and reductive branches of the
TCA cycle [29]. The oxidative route yields a theoretical
maximum of 1 mol succinate/mol glucose. Metabolic en-
gineering strategies have been tried and tested success-
fully for this first route [30, 31]. The reductive pathway,
usually associated with anaerobic conditions, involves
succinate production through carbon dioxide fixation
and relies on pyruvate carboxylation into oxaloacetate
from which TCA metabolites up to fumarate can be syn-
thesized. Fumarate reductase catalyses the conversion
from fumarate to succinate.
Fig. 4 Relative frequencies of the most common knockout combinations across all solution sets from the succinate case study. Darker shades of
blue represent higher knockout frequencies. Labels for each reaction include its identifier in the model as well as the Enzyme Commission
number attributed to it according to the iMM904 model reconstruction used in this work
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Early efforts using yeasts as succinate-overproducing
microbes have focused on the enhancement of sake
brewing processes with Saccharomyces cerevisiae [32].
This study describes, among others, a strain with a suc-
cinate dehydrogenase (SDH) gene disruption that leads
to increased succinate production in aerobic conditions.
A similar finding is confirmed in another study, showing
that disruption of any of the SDH subunits leads to in-
creased aerobic succinate production and that higher
succinate titres could be correlated with lower SDH
complex activity [33].
Additionally, it is shown that growth and substrate up-
take are not significantly altered in strains with disrupted
pairs (SDH1 and SDH2) [33]. The structural analysis fea-
tured in this work reveals that inactivation of at least
two subunits of the SDH system (along with further
knockouts) is required to allow strongly coupled produc-
tion of succinate. Another yeast strain with a SDH2
knockout was experimentally tested, albeit on a different
species (Yarrowia lipolytica), resulting in production at a
minimum of 56% of the theoretical maximum [34]. The
results obtained in our analysis are in accordance with
experimental data regarding the SDH2 knockout which
is an essential component of strongly coupled strategies.
Further studies found improved strategies for aerobic
succinate production in yeast. The addition of a isoci-
trate dehydrogenase (IDH) knockout to the SDH1/2 pair
was studied as a means of diverting citric acid cycle in-
termediates into the glyoxylate cycle, resulting in succin-
ate overproduction [31]. This mutant was able to
achieve a yield almost four times greater than the wild-
type strain and the addition of a mitochondrial isocitrate
dehydrogenase knockout (IDP) leads to even higher suc-
cinate concentrations at the cost of reduced growth rate
[31]. Some strongly coupled solutions featured in this
work exhibit glyoxylate cycle flux, although these have
low representation within the entire solution set.
An alternative strategy for glyoxylate shunt carbon re-
direction was presented by Otero et al. [30], involving
two knockouts, namely at the SER3/SER33 gene (catalys-
ing the PGCD reaction in the iMM904 metabolic model)
and at subunit 3 of the SDH complex. Carbon flux is
redirected towards glyoxylate to allow serine production,
with succinate as a by-product of using this metabolic
route. This strategy was developed using in silico tools
and then experimentally tested. Not surprisingly, some
of the solutions obtained in the present work include
those strategies.
There is in vivo evidence that succinate production in
Saccharomyces cerevisiae from the GABA shunt is re-
sidual in normal fermentation conditions (with oxygen
limitation) [35]. It is still unclear whether the GABA
shunt is a valid alternative for succinate production in
aerobic conditions, but our results make this pathway a
relevant candidate for further study in aerobic
conditions.
Regarding the reductive pathway, not many efforts
have been implemented regarding the optimization of
this route, mainly due to cofactor imbalances. However,
reported strategies involve the deletion of fermentative
competing pathways, as observed in some of our solu-
tions [36].
Discussion
In this work, we present a comparison of two relevant
constraint-based strain design approaches for ME appli-
cations through in silico analysis of the resulting knock-
outs strategies. Two alternative formulations for MCS
enumeration were tested, yielding mutants with varying
growth and production demands, demonstrating the
flexibility of the intervention problem framework
coupled with the MCSEnumerator algorithm. The re-
sults shown in this work reinforce the importance of
MCSs as a rational approach for ME applications.
When comparing EA and MCS-derived strategies,
there is a clear trade-off between robustness and max-
imum cell growth. Growth-coupling strength increases
as maximum biomass decreases, leading to strongly-
coupled cMCSs with high product flux and low growth
and weakly-coupled EA strategies with opposing fea-
tures. Phenotypes with very high yields have been found
using cMCSs, largely surpassing those from SPEA2, but
cell viability is still unknown as the low cell growth rate
may indicate that these strategies incur in lethal modifi-
cations in vivo.
Nevertheless, it is still possible to obtain growth-
coupled phenotypes with low production robustness,
using the MCSw formulation firstly described in this
work. Strategies obtained using this method have lower
predicted productivity, but overall higher growth rates.
While possibly unsuitable for direct in vivo application,
these strategies may serve as starting points for other
strain design algorithms, upon which more knockouts
can be added to achieve higher productivity.
With the EAm formulation, SPEA2 can also be used
to obtain strongly-coupled strategies, with similar ro-
bustness to those found using MCSEnumerator. How-
ever, the latter can enumerate smaller strategies, which
is advantageous for in vivo implementation.
The MCSf formulation presented and tested in this
work allowed us to find strategies with high product flux
values and robustness but lower cell growth rates over-
all. This helped us reveal the importance of including a
coupling component (such as the maintenance ATP as-
sumption on the MCSe formulation) when searching for
MCS-based strategies. Indeed, when the maintenance
ATP assumption is replaced with a fixed substrate con-
straint, other cofactor wasting mechanisms arise.
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For practical purposes, it is clear that EAw strategies
confer high BPCY at a relatively low number of knock-
outs to achieve that goal. However, product synthesis
can only be guaranteed with growth rates close to the
wild-type, which casts uncertainty on whether these
strategies will have a noticeable effect in vivo.
The strong growth-coupling knockouts suggested by
MCS enumeration have practical implications concerning
their size, which exceeds six knockouts in the best possible
case, aside from the relatively low growth rate and BPCY.
However, they are promising candidates for adaptive la-
boratory evolution, since the target organism may acquire
mutations that lead to increased growth rates while main-
taining the growth-coupling with product synthesis.
Moreover, using multiple strain design approaches
with varying productivity and robustness demands fur-
ther helped us to find knockouts providing a beneficial
compromise between maximum cell growth, production
flux and yields.
The findings from the Saccharomyces cerevisiae case
study featured in this work show that strongly growth-
coupled strategies point towards increased usage of the
GABA degradation pathway as production demands
grows, at the cost of lower growth rates. This design
strategy requires further experimental validation, despite
the existence of studies acknowledging it as a potential
ME target for succinate production.
This work only includes CSOMs for finding sets of re-
action deletions; however, it is possible for both methods
to also suggest strategies involving modification of the
expression levels of metabolic genes [37], which could
be addressed as a future case study.
Conclusions
Overall, we conclude that EMA-based CSOMs are valu-
able tools for strain design that yield design strategies with
the highest production fluxes and robustness and uncover
the biochemical mechanisms that lead to these phenom-
ena. A thorough analysis of these algorithms’ outputs
serves as valuable tool for guiding rational approaches to
strain optimization by highlighting relevant deletions to
achieve the ME goal. Aiming for both weak and strong
coupling phenotypes using these algorithms is essential to-
wards finding a compromise between viability and prod-
uctivity and identifying common targets whose
modification is essential to produce a given compound.
We show that it is possible to fine-tune the compromise
between robustness and growth rates by choosing differ-
ent algorithms or setups among those tested in this work.
Methods
Constraint-based modelling and analysis
In this work, we attempt to find design strategies for Sac-
charomyces cerevisiae using the iMM904 reconstruction
presented by Mo and colleagues [38] with additional
changes proposed by Pereira et al. [39] for improved pre-
dictive accuracy.
The constraint-based approach to modelling repre-
sents stoichiometry restricted by steady-state [40],
through a system of linear equations complemented with
inequalities representing bounds for each flux. Such a
system is formulated as shown on Eq. 1, assuming S as a
m-by-n matrix encoding the network stoichiometry, v as
the flux vector, and l,u as the vectors encoding the lower
and upper bounds, respectively.
S:v ¼ 0
li≤vi≤ui∀i∈ 1;…; nf g
l; v; u∈ℝn
ð1Þ
Typical approaches such as Flux Balance Analysis
(FBA) [2] attempt to find a single flux distribution, by
optimizing towards a given objective function, subject to
the previously mentioned constraints.
The most common approach is to maximize cell
growth, although other functions have also been pro-
posed, mainly to address phenotype prediction in mu-
tant cells [3, 4]. The optimization problem posed by
FBA typically leads to multiple optima for the same ob-
jective, eliciting the development of alternative methods
for prediction and analysis of simulated fluxes such as
parsimonious FBA (pFBA) or Flux Variability Analysis
(FVA).
These two methods are later used to analyse the per-
formance of our design strategies. pFBA extends the
FBA problem by constraining the optimum to that
which minimizes overall flux usage (sum of absolute flux
values) [5] and FVA provides theoretical maximum and
minimum flux values for the model/environmental con-
dition assuming a fraction of the maximum growth rate
[41].
An alternative approach to analyse fluxes using
constraint-based models is to employ convex analysis,
usually with EMA methods, since the linear system of
equations is a convex polyhedral cone when all reactions
are irreversible [42], which is usually achieved by re-
placing reversible reactions with two forward and back-
ward fluxes.
EMA is based on the concept of elementary modes
(EM), defined as any flux distribution e that solves the
system in Eq. 1 containing only irreversible reactions,
such that: (1) two split reversible reactions are not sim-
ultaneously active; (2) e is a feasible solution, thus satis-
fying steady-state and thermodynamic constraints: (3) if
an active reaction of e is removed, e is no longer feasible.
These properties assure EMs are the smallest sets of re-
actions allowing valid metabolic conversions, and any
steady-state flux distribution complying with
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thermodynamic constraints can be defined as a linear
combination of the full set of EMs [6].
Minimal cut sets (MCSs) are an extension of this con-
cept, defining sets of reactions that, when removed or
blocked, disable certain selected EMs [17]. With appro-
priate EMs to block, it is possible to find minimal strat-
egies to achieve or even guarantee the expression of
desired phenotypes. Constrained MCSs (cMCSs) extend
this concept even further to guarantee that desired phe-
notypes are not among those that are blocked [43].
The intervention problem framework, first presented
by Hädicke et al. [43], provides a flexible approach for
formulating ME problems with cMCSs. An intervention
problem I (T, D) requires two inputs, namely:
1. Target flux space (T), containing undesired EMs to
be blocked.
2. Desired flux space (D), comprising desirable EMs,
which cannot be blocked.
For any problem I, the resulting MCSs will render the
EMs in T invalid while also keeping EMs in D active.
For this reason, not all MCSs for I can be considered
cMCSs [43]. Both T and D can be defined as part of the
solution space of the flux vector v, leading to the linear
system in Eq. 2, when supplied with a b vector. These
formalisms allow the definition of spaces to block
through well-defined bounds for certain fluxes, bypass-
ing the need for selecting specific EMs.
T 1;1 ⋯ T 1;n
⋮ ⋱ ⋮
Tm;1 ⋯ Tm;n
2
4
3
5:v≥ b1⋮
bm
2
4
3
5 ð2Þ
Growth-coupled product synthesis
The objective of virtually all CSOMs is to find subnet-
works in which the flux to be optimized is guaranteed to
be active, considering some restrictions. Growth coup-
ling with production occurs when there is at least one
possible flux vector where the production flux p is kept
above a threshold pmin and the growth pseudo-flux b is
kept above a minimum bmin. This definition is broad,
and thus, two types of growth coupling can also be dis-
tinguished. It should also be noted that the original def-
inition involves product and growth per substrate yields.
Since our experimental conditions assume a fixed sub-
strate uptake rate, these definitions have been adapted
for flux values only.
Strong coupling occurs if all admissible flux vectors
force p to be kept above pmin and at least one of these
allows b to be kept above bmin, implying there is always
product synthesis and that its flux can be coupled with
growth.
Weak coupling, on the other hand, imposes that all
flux vectors where b > bmin must also force p > pmin.
This is a less demanding constraint since the product is
not essential until the growth rate rises above a certain
threshold.
For this work, we set the minimum product and
growth thresholds for coupling at a very small value ε =
10− 4 to avoid arbitrarily discarding growth-coupled solu-
tions with low production fluxes.
Strain optimization algorithms
Multi-objective evolutionary algorithms
In this study, we employ the OptGene method using the
Strength Pareto Evolutionary Algorithm 2 (SPEA2) as
representative of SB CSOMs. This approach allows for
the definition of multiple objective functions [16], pro-
viding a flexible framework for defining appropriate ME
goals. Unlike typical evolutionary algorithms where an
aggregate function must be defined if multiple objectives
are required, SPEA2 evaluates these separately and pri-
oritizes those with the highest Pareto optimality.
The overall algorithm employed in this setup includes
the following steps:
1. Generate an initial random set (population) of
candidate strategies (individuals) containing
reaction knockouts
2. Decode each individual and convert reaction
deletions into flux constraints to be applied to the
CB model
3. Determine the fitness value for each individual
using a suitable objective function. This function
can be linear or nonlinear.
4. Select the best individuals according to their fitness
values. The assumption here is that fitter
individuals will give rise to better offspring
strategies.
5. Replace the population for a new one by applying
mutation and crossover operators to the previous
set of strategies, thus yielding new strategies that
combine reaction knockouts from the fittest
individuals.
6. Obtain the design strategies from the population if
the stopping criteria are met. Otherwise, return to
step 2.
To provide a better comparison with EMA-based
CSOMs, two sets of fitness functions are used. The first
is a typical approach in ME problems, maximizing both
product and biomass fluxes, while the second represents
a search for more robust strategies, enforcing growth-
coupled compound synthesis at lower growth rates to
reach growth-coupling phenotypes similar to those
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found with EMA-based CSOMs. Both are represented
on Table 1 and described in the following.
Biomass-product coupling maximization (EAw)
A multi-objective approach using maximum cell growth
and production flux at maximum cell growth as two sep-
arate objective functions. This represents growth coup-
ling as the strategies are evolved towards increased
product and biomass production values but does not
guarantee strong coupling as it inherently assumes bio-
mass maximization.
Product minimum maximization (EAm)
This approach includes the maximum cell growth rate
and minimum product flux at maximum growth as ob-
jectives. The latter is determined through FVA [41] by
setting biomass production at its maximum and minim-
izing the product flux. Additionally, the cell must always
synthesize the product (product flux above 0) if the
growth rate is at 50% of the theoretical maximum value.
For this work, candidate strategies were subject to a
maximum of 20 deletions. Although that amount of de-
letions is not acceptable for in vivo implementation, we
have decided not to restrict the enumeration with a
smaller strategy size to avoid discarding potentially use-
ful phenotypes for our analysis. Since this is an evolu-
tionary algorithm, a pool of solutions is evolved until a
stopping criterion is reached, in this case being a cap of
105 objective function evaluations. Due to the heuristic
nature of the algorithm, it was executed 10 times for
each case.
MCSEnumerator
The MCSEnumerator approach is based on the findings
of Ballerstein et al. [23] reporting the properties of dual
networks based on original stoichiometric metabolic net-
works. For this problem, we first assume a m-by-n stoi-
chiometric matrix S with reversible and irreversible
reactions identified by sets of indices r and i,
respectively.
The dual network/system is essentially a transposed
and extended network based on the original, where reac-
tions become metabolites and vice-versa and is repre-
sented in Eq. 3. The metabolites representing the
original reactions are produced by newly added reactions
(represented by vectors v and h) and consumed by the
reactions added as part of the target space T. EFMs
enumerated in this network in which fluxes in w are ac-
tive are MCSs of the original network. The original map-
ping is obtained by checking which fluxes in the vectors
v and h are active, and thus, satisfying the demand
caused by the fluxes in w.
Si I −I T i
Sr I −I Tr
 
:
u
v
h
w
2
664
3
775 ≥0¼ 0
b:w
0
> c; c > 0
u∈ℜm
v; h;w∈ℜn0þ
ð3Þ
In MCSEnumerator, this dual network is used as input
for the k-shortest algorithm which is integrated in the
linear problem by adding binary variables for each flux
in v and h which are set to 1 if the respective flux is ac-
tive or 0 otherwise. Additional constraints ensure that
the split reaction pairs cannot be simultaneously active.
Finally, the objective function is set towards the
minimization of the number of active reactions in v and
h.
The intervention problem framework described in the
previous section is used to formulate cMCS enumeration
problems, with all formulations written in the form I(T,
D), with T and D representing flux spaces to block and
keep. The desired space D can be defined as appropriate
environmental conditions supplied as constraints. Add-
itionally, a lower bound constraint on the biomass
pseudo-reaction discards lethal cMCSs. Both T and D
are matrices representing the linear coefficients for in-
equalities in the form T.v ≤ b, assuming v as the flux
vector and b as a vector of size c with one value for each
constraint to add.
Defining target spaces
Different combinations of constraints for the defin-
ition of the target flux space T were tested with
MCSEnumerator. Four main constraint types can be
summarized, namely:
1. Product constraint, indicating that the product
must stay above a certain threshold. Product/
Substrate and Product/Biomass yields, as well as
simple product flux constraints were tested.
Table 1 Overview of the evolutionary algorithm formulations used in this work. Both objective functions are represented, as well as
other constraints that condition the acceptance of a given candidate as a valid solution
Formulation Objective function #1 Objective function #2 Additional constraints
EAw Z = Max (vb) Max(vp) None
EAm Max(W = Min (vp))s. t. vb = Z Accept solution if vp > 0 if vb > Z2
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2. Substrate constraint, either fixed or with an upper
bound on the maximum uptake rate. Can be
considered as an environmental condition
restricting the feasible solution space.
3. Coupling constraint, referring to additional flux
bounds introducing assumptions to the problem to
further restrict the solution space. In our setup, we
have tested a constraint to set the flux of the
maintenance ATP pseudo reaction.
4. Biomass constraint, where a biomass lower bound
is set to further restrict the target flux space.
From this early analysis, we have determined that biomass
constraints together with product yield constraints nega-
tively affect computational speed, and do not result in add-
itional solutions. Furthermore, we have also determined that
non-fixed substrate constraints require an additional coup-
ling component, otherwise leading to an infeasible enumer-
ation problem. In such scenarios, it is possible that the
origin point of the flux cone is included in the undesired
space, for which there are no MCSs that can block it, should
the problem only contain homogeneous constraints.
Three formulations were selected to consider different
strain design objectives. Table 2 highlights the con-
straints used in these formulations, which are:
 MCSe: The undesired space contains low product
yield flux vectors with a maximum substrate uptake
rate of smax and maintenance ATP rate above m. A
similar formulation is employed in Escherichia coli
ME case studies with MCSEnumerator [22].
 MCSf: Low product yield phenotypes are blocked,
but assuming a fixed substrate uptake rate of smax.
The aim is to eliminate the maintenance ATP
assumption, while maintaining the origin point of
the flux cone out of the undesired space.
 MCSw: This formulation attempts to find less
robust solutions by blocking low product flux
phenotypes only when biomass fluxes are above a
fraction F of bmax (maximum growth rate). The aim
is to try and reach strategies with less strict
demands regarding product synthesis and its
coupling with growth. While many strategies may
not allow growth-coupling at all, some weak-
coupled cMCSs can theoretically be found using this
formulation.
Filtering
Strategies from the optimization algorithms were filtered
according to their expected growth-coupling strength. A
filtering pipeline using FVA [41] was developed to en-
sure that three key conditions were met, namely:
 Compliance with environmental conditions:
Strategies must be feasible with substrate uptake and
maintenance ATP constraints, among others;
 Growth rate: Maximum mutant growth rates must
reach at least 1% of the wild-type strain;
 Growth-coupling with product: Mutants must
carry non-zero product flux with the cell at or above
90% of the maximum mutant growth rate (growth
coupling phenotypes).
It is worth noting that while the MCSe and MCSf for-
mulations would always lead to growth-coupled cMCSs,
this is not the case for MCSw nor solutions based on
evolutionary algorithms. Thus, this step is required to
discard any strategy that does not lead to growth-
coupled production.
Analysis
A global assessment of the selected solution sets was
performed regarding four key aspects:
 Performance – Predict production titres and
robustness;
 Pathways – Compare overall pathway usage across
strategy groups;
 Phenotype – Investigate individual strategies from
various groups to find mechanisms leading to
growth-coupling phenotypes;
 Structure – Assess the impact of individual
knockouts in each strategy group relative to their
phenotype/pathway pattern.
The constraints and objective functions used to obtain
the productivity metrics are highlighted on Table 3.
These metrics are:
 Production robustness: Minimum feasible
production rate given a lower limit for cell growth.
Production is considered robust for a certain
Table 2 Overview of the constraints for the undesired space (T) used in formulations involving enumeration of constrained minimal
cut sets
Formulation Product constraint Substrate constraint Coupling constraint Biomass constraint
MCSe vp
vs
≤ymin vs ≤ smax vatp≥m None
MCSf vs = smax None
MCSw vp≤ ε vs = smax None vb≥ F. bmax
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biomass threshold, if the corresponding minimum
rate is not null.
 Predicted fluxes: Assuming the pFBA flux
distribution as the predicted phenotype, maximum
cell growth, substrate uptake and production rate
fluxes are obtained and considered as predictions of
in vivo behaviour.
 Production yield: Biomass-product coupled yield
[14] was used to assess the productivity of the mu-
tant strains, since it takes cell growth, production
rate and substrate uptake into account.
Using the pFBA flux distributions for all the mutant
strains, it is possible to compare pathway usage across
various sets of solutions. With the wild-type distribution
as reference, the purpose is to find how different groups
of strategies influence pathway usage.
Consider a n-by-m binary matrix p with n pathways and
m reactions. Each element pnm has a value of 1 if reaction m
is part of a pathway n, and 0 otherwise. For each strategy
with a flux distribution v, a “pathway distribution” is given
by d (v, p), a vector with n elements, one for each pathway,
containing the number of active reactions for each pathway.
d v; pð Þ ¼
Pm
i¼1 pji: sgn við Þj j
 
Pm
i¼1pji
∀ j∈ 1;…; nf g ð4Þ
For each strategy in a given group, a pathway distribution
is generated according to the formula in Eq. 4, assuming
sgn(x) as the sign function of x. Assuming this is performed
for s solutions, a s × n matrix P can be assembled, contain-
ing all of the pathway distributions for the strategy set. The
global difference from the wild-type can be found through
determination of the mean value for each pathway in P and
subtracting it to the corresponding value in the wild-type.
Software
Enumeration of cMCSs was performed using mcslibrary
[44], an open-source Java library implementing the
methods described by Von Kamp and associates used for
MCSEnumerator [22]. The tool, developed in-house, has
been validated using the case studies that were also applied
to MCSEnumerator. The analysis pipeline for the entire set
of design strategies was also performed using this tool.
Source-code and test scripts are available from the Git
repository at https://github.com/MEWorkbench/mcslibrary.
A graphical user interface implementing some functional-
ities of this library is available as a plugin (optflux-mcs) for
the OptFlux ME software platform [45]. Currently on its
third major release, it is an open-source tool that allows
users to load metabolic models and use a wide array of
phenotype prediction methods and CSOMs in a user-
friendly setting.
Our SPEA2 workflow is currently available as part of
the MEWorkbench’s mewcore library containing core
methods used within OptFlux for simulation, analysis and
strain optimization. Source-code is available on the Git re-
pository at https://github.com/MEWorkbench/mewcore.
The evolutionary algorithm is part of JECoLi (Java Evolu-
tionary Computation Library), a library implementing
generic evolutionary algorithms with source code available
at https://github.com/jecoli/jecoli.
Data analysis and plots shown in this work were proc-
essed using the R programming language. Scripts to per-
form this analysis are available at http://www.bio.di.
uminho.pt/csomcomparison/.
Availability and requirements
Project name: mcslibrary.
Project home page: https://github.com/MEWork-
bench/mcslibrary
Operating systems(s): Platform independent.
Programming language: Java.
Other requirements: IBM® ILOG® CPLEX® Optimizer
version 12 or higher, Java® 1.7 or higher.
License: GNU Lesser General Public License 2.1.
Endnotes
1https://github.com/MEWorkbench
Additional file
Additional file 1: Compound overproduction in Escherichia coli using
minimal cut set based strain design. (DOCX 296 kb)
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